KEGG enrichment pathway analysis highlighted the downregulation of four genes such as Gpat4, Gpcpd1, Chkb, and Etnppl. These findings contribute to our understanding of the metabolic changes associated with MASLD. Here, GPCPD1 is linked to metabolic dysfunction-associated steatotic liver disease.